257 related articles for article (PubMed ID: 20224464)
1. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.
Aziz HA; Boutrid H; Murray TG; Berrocal A; Wolfe SQ; Pina Y; Dorfman M; Moftakhar R; Fernandes CE; Reichbach J; Aziz-Sultan MA
Retina; 2010 Apr; 30(4 Suppl):S63-5. PubMed ID: 20224464
[TBL] [Abstract][Full Text] [Related]
2. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
Abramson DH; Dunkel IJ; Brodie SE; Kim JW; Gobin YP
Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan.
Hadjistilianou T; Coriolani G; Bracco S; Gennari P; Caini M; Cerase A; Galimberti D; De Francesco S; De Luca M; Mastrangelo D
J Pediatr Ophthalmol Strabismus; 2014; 51(1):32-8. PubMed ID: 24308859
[TBL] [Abstract][Full Text] [Related]
4. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
Muen WJ; Kingston JE; Robertson F; Brew S; Sagoo MS; Reddy MA
Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
7. Hemorrhage as a sign of treatment failure after intra-arterial chemotherapy in retinoblastoma.
Silva RA; Dubovy SR; Hess D; Stratton R; Murray TG
J AAPOS; 2015 Jun; 19(3):268-70. PubMed ID: 25907829
[TBL] [Abstract][Full Text] [Related]
8. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
Suzuki S; Yamane T; Mohri M; Kaneko A
Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of retinoblastoma following intra-arterial chemotherapy.
Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
[TBL] [Abstract][Full Text] [Related]
10. Verification of supraselective drug delivery for retinoblastoma using intra-arterial gadolinium.
Materin MA; Kuzmik GA; Jubinsky PT; Minja FJ; Asnes JD; Bulsara KR
J Neurointerv Surg; 2013 Nov; 5(6):e42. PubMed ID: 23188789
[TBL] [Abstract][Full Text] [Related]
11. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
Peterson EC; Elhammady MS; Quintero-Wolfe S; Murray TG; Aziz-Sultan MA
J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
[TBL] [Abstract][Full Text] [Related]
12. INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA IN A 2-MONTH-OLD INFANT.
Magan T; Khoo CT; Jabbour PM; Shields CL
Retin Cases Brief Rep; 2017 Winter; 11(1):24-26. PubMed ID: 26756523
[TBL] [Abstract][Full Text] [Related]
13. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
Hutchinson A; Kaliki S; Shields CL
J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587
[TBL] [Abstract][Full Text] [Related]
14. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
15. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
16. Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.
De Freytas A; Harto-Castaño M; Barranco H; Aviño J; Martinez-Costa R
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):487-90. PubMed ID: 26008929
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients.
Schaiquevich P; Buitrago E; Taich P; Torbidoni A; Ceciliano A; Fandino A; Asprea M; Requejo F; Abramson DH; Bramuglia GF; Chantada GL
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4205-12. PubMed ID: 22628208
[TBL] [Abstract][Full Text] [Related]
18. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
De Francesco S; Galluzzi P; Bracco S; Menicacci F; Motolese E; Hadjistilianou T
Int Ophthalmol; 2015 Dec; 35(6):887-95. PubMed ID: 26416040
[TBL] [Abstract][Full Text] [Related]
19. Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma.
Jabbour P; Chalouhi N; Tjoumakaris S; Gonzalez LF; Dumont AS; Chitale R; Rosenwasser R; Bianciotto CG; Shields C
J Neurosurg Pediatr; 2012 Sep; 10(3):175-81. PubMed ID: 22793160
[TBL] [Abstract][Full Text] [Related]
20. Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.
Venturi C; Bracco S; Cerase A; Cioni S; Galluzzi P; Gennari P; Vallone IM; Tinturini R; Vittori C; De Francesco S; Caini M; D'Ambrosio A; Toti P; Renieri A; Hadjistilianou T
Acta Ophthalmol; 2013 Jun; 91(4):335-42. PubMed ID: 22268993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]